Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.

Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, Skarbinski J, Higa DH, Prejean J, Frazier EL, Patel R, Huang P, An Q, Song R, Tang T, Valleroy LA.

MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1113-7.

2.

Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia.

Olsen MF, Kæstel P, Tesfaye M, Abdissa A, Yilma D, Girma T, Mølgaard C, Faurholt-Jepsen D, Christensen DL, Brage S, Andersen ÅB, Friis H.

Epidemiol Infect. 2015 Apr;143(5):1048-58. doi: 10.1017/S0950268814001502. Epub 2014 Jun 24.

PMID:
25034136
3.

Aerobic fitness levels and validation of a non exercise VO2max prediction equation for HIV-infected patients on HAART.

Sullivan K, Shikuma CM, Chow D, Cornelius E, Romine RK, Lindsey RA, Stickley CD, Kimura IF, Hetzler RK.

HIV Clin Trials. 2014 Mar-Apr;15(2):69-77. doi: 10.1310/hct1502-69.

PMID:
24710921
4.

Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.

Barbour JD, Jalbert EC, Chow DC, Gangcuangco LM, Norris PJ, Keating SM, Heitman J, Nagamine L, Seto T, Ndhlovu LC, Nakamoto BK, Hodis HN, Parikh NI, Shikuma CM.

Atherosclerosis. 2014 Jan;232(1):52-8. doi: 10.1016/j.atherosclerosis.2013.10.021. Epub 2013 Oct 31.

5.

Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.

Spreen W, Min S, Ford SL, Chen S, Lou Y, Bomar M, St Clair M, Piscitelli S, Fujiwara T.

HIV Clin Trials. 2013 Sep-Oct;14(5):192-203. doi: 10.1310/hct1405-192.

PMID:
24144896
6.

Short-term folinic acid supplementation improves vascular reactivity in HIV-infected individuals: a randomized trial.

Grigoletti SS, Guindani G, Moraes RS, Ribeiro JP, Sprinz E.

Nutrition. 2013 Jun;29(6):886-91. doi: 10.1016/j.nut.2013.01.015.

PMID:
23660169
7.

Prevalence and factors associated with a prolonged QTc interval in a cohort of asymptomatic HIV-infected patients.

Moreno T, Pérez I, Isasti G, Cabrera F, Santos J, Palacios R.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1195-8. doi: 10.1089/AID.2013.0061. Epub 2013 May 31.

PMID:
23638650
8.

Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?

Monteiro P, Miranda-Filho DB, Bandeira F, Lacerda HR, Chaves H, Albuquerque MF, Montarroyos UR, Ximenes RA.

Braz J Med Biol Res. 2012 Sep;45(9):818-26. Epub 2012 Jul 12.

9.

Vital signs: HIV prevention through care and treatment--United States.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23.

10.

Control of medical comorbidities in individuals with HIV.

Monroe AK, Chander G, Moore RD.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):458-62. doi: 10.1097/QAI.0b013e31823801c4.

11.

Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.

Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, McFarland N, Thabane L, McIvor A, Zeidler J, Smieja M.

AIDS Patient Care STDS. 2012 Jan;26(1):12-9. doi: 10.1089/apc.2011.0199. Epub 2011 Oct 18.

12.

Increased prevalence of albuminuria in HIV-infected adults with diabetes.

Kim PS, Woods C, Dutcher L, Georgoff P, Rosenberg A, Mican JA, Kopp JB, Smith MA, Hadigan C.

PLoS One. 2011;6(9):e24610. doi: 10.1371/journal.pone.0024610. Epub 2011 Sep 13.

13.

A randomized, clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology and metabolic parameters of patients with AIDS in Salvador, Brazil.

Ogalha C, Luz E, Sampaio E, Souza R, Zarife A, Neto MG, Netto E, Brites C.

J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 3:S179-85. doi: 10.1097/QAI.0b013e31821e9bca.

PMID:
21857315
14.

Refractory hypoxia in an HIV-infected patient--a diagnostic challenge.

Wayangankar SA, Golwala H, Bronze MS.

Am J Emerg Med. 2012 Sep;30(7):1322.e5-6. doi: 10.1016/j.ajem.2011.06.021. Epub 2011 Aug 25.

PMID:
21871757
15.

Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia.

Chow DC, Wood R, Choi J, Grandinetti A, Gerschenson M, Sriratanaviriyakul N, Nakamoto B, Shikuma C, Low P.

HIV Clin Trials. 2011 May-Jun;12(3):141-50. doi: 10.1310/hct1203-141.

16.

Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.

Askgaard G, Kristoffersen US, Mehlsen J, Kronborg G, Kjaer A, Lebech AM.

PLoS One. 2011;6(5):e20196. doi: 10.1371/journal.pone.0020196. Epub 2011 May 31.

17.

Dialysis-associated morbidity, ultrafiltration, and cardiovascular variables in children with HIV infection.

Gordillo R, Del Rio M, Woroniecki RP.

Clin Nephrol. 2011 May;75(5):434-9.

PMID:
21543023
18.

Negative influence of HIV infection on day-night blood pressure variability.

De Socio GV, Bonfanti P, Martinelli C, Ricci E, Pucci G, Marinoni M, Vitiello P, Menzaghi B, Rizzardini G, Schillaci G.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):356-60. doi: 10.1097/QAI.0b013e3181e46456.

PMID:
20562709
19.

Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults.

Pullinger CR, Aouizerat BE, Gay C, Coggins T, Movsesyan I, Davis H, Kane JP, Portillo C, Lee KA.

Metab Syndr Relat Disord. 2010 Jun;8(3):279-86. doi: 10.1089/met.2009.0094.

20.

Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.

Cade WT, Reeds DN, Mondy KE, Overton ET, Grassino J, Tucker S, Bopp C, Laciny E, Hubert S, Lassa-Claxton S, Yarasheski KE.

HIV Med. 2010 Jul 1;11(6):379-88. doi: 10.1111/j.1468-1293.2009.00801.x. Epub 2010 Jan 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk